US revives drug origin debate, cites Indian exports
Washington, Jan 30 (IANS) US lawmakers renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid-19 pandemic by India as evidence that America’s drug supply remains vulnerable to foreign disruptions.